Glaxosmithkline plc (GSK)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Glaxosmithkline plc (GSK)
218 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on GSK
- SA Editor Miriam Metzinger(18)
- SA Editor Eli Hoffmann(17)
- Derek Lowe(17)
- ChinaBio Today(16)
- Centient Biotech Investor(15)
Most popular authors
(tracked in watchlists)
- Philip Davis(740)
- Bill Cara(482)
- SA Editor Eli Hoffmann(413)
- Roger Nusbaum(405)
- Mike Stathis (337)
Most commented on authors
- Mike Stathis (61)
- SA Editor Eli Hoffmann(49)
- SA Editor Miriam Metzinger(30)
- Andrew Mickey(26)
- Derek Lowe(26)
- Indian Markets Friday Wrap-Up: Lower Inflation Fails to Cheer
- Hedge Fund Portfolio Tracking: Renaissance Technologies (Jim Simons), Q3 2008
- 5 U.K. Listed Stocks Look Attractive for 2009
- Seven Top Global Healthcare Stocks in Review
- Drugmakers See Healthy Profits on Flu Pandemic Watch
- Immunogen and Exelixis Defy the Recession
- Global Investing Economic Outlook for 2009
- Stem Cell and Regenerative Medicine Stocks Surge in December
- GlaxoSmithKline Allies With Dynavax to Target Autoimmune Diseases
- Recession-Proof? The Beauty of Big Pharma Is in the Eye of the Beholder
- Top 10 Global Personal Care Products Makers
- Nine Pharma Predictions for 2009
- Trial Results Don't Look Good for GlaxoSmithKline's Diabetes Drug
- China Biopharma News Back in the Spotlight
- Navigating the Micro-Cap Biotech Minefield
- 73 Decision Dates on Updated FDA Calendar
- Big Pharma Steps Up China Investment
- Regenerative Medicine: Big Pharma's Next Frontier
- Updated FDA Decision Date Calendar
- Highly Defensive ETFI: Lower Volatility, Higher Returns
- Boning Up on Amgen's D-mab for Osteoporosis
- Backlog of Decisions Is Building at the FDA
- Gold Miners: Biggest Drag on My Portfolio, Yet the Biggest Opportunity
- GlaxoSmithKline to Acquire Genelabs Technologies For $57M
- Glaxo and AFFiRiS Sign Alzheimer’s Disease Vaccine Deal
- Don't Buy Into Share Buybacks
- Are Pfizer and Lilly's ED Drugs Suffering from the Economic Slowdown?
- Ten Highest Yielding Pharma Stocks
- 'When There's Blood in the Streets', Buy Biotech Stocks
- FDA Publishes List of Potential Drug Risks
- Licensing Deal Is Imminent for ArQule
- Hard Times Hit Biotech
- Pfizer Cuts Back - But Is It Slimming Down for ImClone?
- Roche Covets Genentech for Good Reason
- Expiring Patents Ignite Biotech Boom
- Sinovac Launches New Version of Flu Vaccine
- GSK and Cellzome in Kinase Technology Alliance
- Latest FDA Report Highlights: 8 Drugs That Carry Potential Risks
- Yangtze River Delta Developing Huge R&D Base for Drug Companies
- 5 Big Pharma Cash Machines
- Why Dividend Investors View Stocks Differently
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
3 new today)